ncRNA name
CRNDE
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-33a/HMGA2
Cancer name
Liver Cancer
Cancer site
Liver
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Down
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Downregulated CRNDE and upregulated miR-33a-inhibited cells drug-resistance and promoted their apoptosis in liver cancer drug-resistant cells.
Tissue resource
liver cancer cell lines HepG2
liver cancer cell lines BEL-7402
Experiment
qRT-PCR,Western blot,Dual-Luciferase reporter assay
Institute
Shanghai Cell Bank, Chinese Academy of Sciences
Country
China
Continent
Asia